- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00554541
Lower Extremity Venous Hemodynamics in Obese Patients Without Clinically Significant Venous Disease
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Disease of the veins include blood clots, varicose veins, leg swelling, and sores on the legs. Venous disease is more common in overweight patients, but little is known as to why this is the case. This research project is investigating the relationship between body weight and function of the leg veins using a special non-invasive technique known as venous plethysmography. We hope to investigate the reason for the relationship between body weight and higher risk of vein problems.
Approximately 45 people will take part in this study. Patients will be recruited from among three groups: normal weight people, overweight people, and obese people.
Resting ankle-brachial index will be measured in both lower extremities to exclude the presence of peripheral arterial disease. Venous physiologic study using air plethysmography with positional maneuvers will be performed. Parameters to be measured will be outflow time, passive draining and refill time, and exercise venous plethysmography. All studies will be performed with the Phlebotest system (Osborn Medical).
All study procedures will be done during one visit, and no further follow-up is required.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Ohio
-
Cleveland, Ohio, United States, 44195
- Cleveland Clinic Foundation
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Age between 18-60 years old
- BMI within one of three strata (Normal: 18.5-24.9, Obese: 30.0-39.9, Morbidly Obese: ≥ 40)
Exclusion Criteria:
- Prior diagnosis of chronic venous insufficiency or venous stasis ulceration
- Prior diagnosis of lymphedema
- Significant lower extremity edema as determined by study investigators. Lipidemia (in the absence of venous or lymphatic related edema) is acceptable.
- Varicose veins (subcutaneous dilated vein > 3 mm in diameter measured in upright position). Subjects with telangiectasias and/or mild reticular veins will be eligible (CEAP C1)
- Patients who have been prescribed compression stockings by a health care provider at any time in the past, aside from prophylactic use during prior hospitalization to prevent VTE
- Patients who have undergone any procedure for treatment of lower extremity varicose veins, including: sclerotherapy, venous ablation, phlebectomy, or a stripping procedure
- History of DVT or SVT
- Pregnancy
- Active malignancy
- Documented hypercoagulable state
- Body weight exceeds weight limit of the venous air plethysmograph chair equipment (approximately 375 lbs)
- Clinical diagnosis of lower extremity peripheral arterial disease or abnormal ankle-brachial index (ABI) in either lower extremity
- History of surgical intervention involving pelvis or lower extremities
- Pelvic or lower extremity radiation
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Normal Body-Mass
BMI Index: 18.5-24.9
Ankle Brachial Index Venous physiologic study
|
Assessment of lower extremity venous disease
Other Names:
|
|
Obese Body-Mass
BMI Index: 30.0-39.9
Ankle Brachial Index Venous physiologic study
|
Assessment of lower extremity venous disease
Other Names:
|
|
Morbidly Obese Body-Mass
BMI Index: ≥ 40 Ankle Brachial Index Venous physiologic study
|
Assessment of lower extremity venous disease
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
The purpose of this study is to investigate the reason for the relationship between body weight and higher risk of venous problems.
Time Frame: single time point
|
single time point
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Heather Gornik, MD, RVT, The Cleveland Clinic
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 07-617
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obesity
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | Obesity and Obesity-related Medical ConditionsUnited States
-
Central Hospital, Nancy, FranceNot yet recruiting
-
Helsinki University Central HospitalKarolinska Institutet; Folkhälsan Researech CenterEnrolling by invitation
-
Istanbul Medipol University HospitalMedipol UniversityCompletedObesity, Morbid | Obesity, Adolescent | Obesity, Abdominal | Weight, Body | Obesity, VisceralTurkey
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; Pennington Biomedical Research... and other collaboratorsCompletedOvernutrition | Nutrition Disorders | Overweight | Body Weight | Pediatric Obesity | Body Weight Changes | Childhood Obesity | Weight Gain | Adolescent Obesity | Obesity, Childhood | Overweight and Obesity | Overweight or Obesity | Overweight AdolescentsUnited States
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | GLP-1 | Obesity and Obesity-related Medical Conditions | Ablation TechniquesUnited States
-
Azienda Ospedaliero-Universitaria Consorziale Policlinico...Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies; Istituti... and other collaboratorsCompletedMorbid Obesity | Metabolically Healthy ObesityItaly
-
The Hospital for Sick ChildrenCompleted
-
Ihuoma EneliCompletedObesity, ChildhoodUnited States
-
Queen Fabiola Children's University HospitalNot yet recruitingMorbid Obesity | Adolescent Obesity | Bariatric SurgeryBelgium
Clinical Trials on Ankle Brachial Index Venous physiologic study
-
University of AthensMicrolifeCompleted
-
Assiut UniversityNot yet recruitingDiabetic Foot Disease | Chronic Kidney Disease Due to Type 2 Diabetes Mellitus
-
Instituto Nacional de Ciencias Medicas y Nutricion...CompletedAcquired Immunodeficiency Syndrome | HIV | Arterial InsufficiencyMexico
-
University of SouthamptonBerkshire Healthcare NHS Foundation TrustCompleted
-
University Hospital, LimogesCompletedPeripheral Arterial Disease, Ankle Brachial Index, DopplerFrance
-
University of Erlangen-Nürnberg Medical SchoolCompleted
-
Imperial College LondonUniversity of Edinburgh; Universidad de Granada; University of LeicesterCompletedDiabetic Foot | Peripheral Arterial Disease | Peripheral Vascular Diseases | Diabetic Foot Ulcer | Peripheral Artery Disease | Critical Limb Ischemia | Critical Lower Limb IschemiaUnited Kingdom
-
AstraZenecaPretium Pty LtdCompletedPeripheral Arterial DiseaseAustralia
-
Universidad de Especialidades Espiritu SantoRecruitingAtherosclerosis | Dementia | Cerebral Small Vessel Diseases | Cognitive Decline | Cardiovascular Risk FactorEcuador
-
Imperial College Healthcare NHS TrustCompletedDiabetic Foot | Peripheral Arterial Disease | Peripheral Vascular Diseases | Diabetic Foot Ulcer | Peripheral Artery Disease | Critical Limb Ischemia | Critical Lower Limb IschemiaUnited Kingdom